Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices; Guidance for Industry and Food and Drug Administration Staff; Availability

Özet

The Food and Drug Administration (FDA) is announcing the availability of the guidance entitled "Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices." This guidance provides a detailed description of the information that should be included in a premarket notification for a magnetic resonance diagnostic device (MRDD).